Profile data is unavailable for this security.
About the company
ONO PHARMACEUTICAL CO., LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates in one business segment. The Pharmaceutical segment involves in the manufacture and sale of drugs for medical and general use. The Company also involves in the clinical development, introduction and derivation of pharmaceuticals.
- Revenue in JPY (TTM)502.67bn
- Net income in JPY127.98bn
- Incorporated1947
- Employees3.76k
- LocationOno Pharmaceutical Co Ltd1-8-2, Kyutaro-machi, Chuo-kuOSAKA-SHI 541-8564JapanJPN
- Phone+81 662635670
- Fax+81 662632976
- Websitehttps://www.ono-pharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Peptidream Inc | 27.97bn | 2.44bn | 255.99bn | 603.00 | 104.48 | 6.38 | 52.26 | 9.15 | 18.85 | 18.85 | 215.77 | 308.51 | 0.4323 | 4.20 | 5.14 | 46,391,190.00 | 3.77 | -- | 4.38 | -- | 59.16 | -- | 8.73 | -- | 3.23 | 2.59 | 0.3505 | -- | 6.93 | -- | -59.81 | -- | -- | -- |
| Sawai Group Holdings Co Ltd | 176.86bn | 17.22bn | 267.73bn | 3.39k | 15.59 | 1.26 | 8.71 | 1.51 | 392.06 | 311.79 | 4,029.61 | 4,854.95 | 0.474 | 1.21 | 2.85 | -- | 3.40 | 0.7104 | 4.60 | 0.9705 | 30.71 | 35.08 | 7.17 | 1.47 | 1.50 | 52.16 | 0.2755 | 88.14 | 8.04 | -0.8249 | 46.82 | -2.33 | 18.15 | 0.00 |
| Tsumura & Co | 150.85bn | 16.71bn | 303.20bn | 4.03k | 17.97 | 1.11 | 10.53 | 2.01 | 219.81 | 219.81 | 1,984.75 | 3,566.54 | 0.3657 | 0.748 | 2.42 | -- | 4.37 | 4.81 | 5.43 | 5.89 | 45.62 | 50.98 | 11.96 | 12.65 | 2.39 | -- | 0.2125 | 32.09 | 7.71 | 4.52 | 1.37 | 2.74 | 17.54 | 5.84 |
| Hisamitsu Pharmaceutical Co Inc | 141.71bn | 13.97bn | 318.18bn | 2.76k | 20.65 | 1.07 | 16.23 | 2.25 | 180.93 | 180.93 | 1,840.27 | 3,497.04 | 0.441 | 3.13 | 3.43 | 51,361,360.00 | 4.49 | 4.22 | 5.25 | 4.82 | 55.73 | 58.62 | 10.18 | 10.03 | 3.76 | -- | 0.0078 | 53.05 | 10.42 | -0.2385 | 18.97 | -6.17 | 28.90 | 0.5989 |
| Kobayashi Pharmaceutical Co Ltd | 176.47bn | 17.71bn | 423.73bn | 3.53k | 23.22 | 1.97 | 17.54 | 2.40 | 233.81 | 233.81 | 2,340.20 | 2,757.18 | 0.6865 | 3.13 | 4.90 | 49,935,770.00 | 6.89 | 8.01 | 8.53 | 10.18 | 55.53 | 56.45 | 10.03 | 12.24 | 2.19 | -- | 0.0046 | 33.19 | 4.33 | 0.7037 | 1.58 | 2.45 | 29.67 | 8.88 |
| Santen Pharmaceutical Co Ltd | 301.97bn | 26.63bn | 592.59bn | 4.14k | 22.27 | 1.93 | 13.20 | 1.96 | 73.11 | 73.11 | 830.17 | 842.64 | 0.7048 | 2.99 | 3.11 | -- | 6.23 | 3.31 | 7.90 | 4.10 | 59.18 | 59.73 | 8.84 | 5.21 | 2.08 | 5.12 | 0.16 | 81.86 | 8.22 | 5.23 | 278.09 | -3.58 | 5.10 | 4.88 |
| Rohto Pharmaceutical Co Ltd | 270.84bn | 30.94bn | 652.09bn | 7.18k | 20.42 | 2.56 | 19.86 | 2.41 | 135.21 | 135.21 | 1,183.69 | 1,079.72 | 0.8259 | 2.59 | 4.17 | -- | 9.57 | 8.54 | 13.02 | 11.79 | 58.07 | 58.59 | 11.59 | 10.30 | 1.93 | -- | 0.0408 | 19.39 | 13.48 | 8.09 | 17.28 | 25.85 | 5.20 | 18.61 |
| Ono Pharmaceutical Co Ltd | 502.67bn | 127.98bn | 1.13tn | 3.76k | 8.55 | 1.35 | 7.76 | 2.26 | 265.98 | 265.98 | 1,046.97 | 1,688.42 | 0.5597 | 2.72 | 4.11 | -- | 14.26 | 11.95 | 16.44 | 13.73 | 74.71 | 74.11 | 25.47 | 23.89 | 3.52 | -- | 0.011 | 32.11 | 12.41 | 11.73 | 13.53 | 19.95 | -6.79 | 12.20 |
| Kyowa Kirin Co Ltd | 454.27bn | 83.06bn | 1.43tn | 5.97k | 17.18 | 1.68 | 13.67 | 3.16 | 154.53 | 154.53 | 845.28 | 1,577.38 | 0.455 | 1.61 | 4.24 | 76,040,840.00 | 8.32 | 6.28 | 9.55 | 7.08 | 74.06 | 75.45 | 18.28 | 14.96 | 3.06 | -- | 0.0272 | 47.25 | 11.01 | 10.25 | 51.55 | 10.52 | 10.28 | 9.86 |
| Eisai Co Ltd | 741.75bn | 42.41bn | 2.00tn | 11.08k | 45.67 | 2.21 | 24.08 | 2.70 | 147.86 | 147.86 | 2,586.28 | 3,050.54 | 0.5583 | 0.986 | 3.92 | -- | 3.30 | 5.29 | 4.36 | 7.16 | 79.06 | 76.91 | 5.90 | 8.68 | 1.80 | -- | 0.1506 | 74.13 | -0.3561 | 2.90 | -23.50 | -7.72 | -2.11 | 1.30 |
| Shionogi & Co Ltd | 435.08bn | 162.03bn | 2.09tn | 5.68k | 12.63 | 1.62 | 11.67 | 4.80 | 557.51 | 557.51 | 1,498.79 | 4,357.54 | 0.3189 | 0.9378 | 3.75 | -- | 11.77 | 12.57 | 13.40 | 14.24 | 86.76 | 84.43 | 36.91 | 37.91 | 5.37 | -- | 0.0092 | 26.41 | 1.97 | 3.41 | -12.40 | 3.38 | 2.17 | 11.22 |
| Astellas Pharma Inc | 1.60tn | 17.05bn | 2.80tn | 14.48k | 164.77 | 1.74 | 16.02 | 1.75 | 9.40 | 9.40 | 892.49 | 890.07 | 0.5322 | 1.38 | 3.33 | -- | 0.5657 | 4.59 | 0.8492 | 6.61 | 81.76 | 80.53 | 1.06 | 7.98 | 0.7358 | 7.32 | 0.3657 | 85.78 | 5.60 | 4.19 | -82.73 | -40.17 | 9.62 | 13.00 |
| Otsuka Holdings Co Ltd | 2.09tn | 137.56bn | 3.61tn | 34.39k | 25.54 | 1.40 | 14.88 | 1.73 | 253.49 | 253.49 | 3,850.84 | 4,629.31 | 0.635 | 2.44 | 4.88 | 60,769,480.00 | 4.31 | 4.80 | 5.34 | 5.88 | 70.03 | 68.21 | 6.78 | 8.36 | 1.63 | -- | 0.0724 | 42.16 | 16.14 | 9.33 | -9.18 | 8.07 | 9.27 | 1.92 |
Data as of May 31 2024. Currency figures normalised to Ono Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
23.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Wellington Management Co. LLPas of 14 Apr 2023 | 24.64m | 4.94% |
| BlackRock Fund Advisorsas of 29 Mar 2024 | 16.77m | 3.36% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 31 Oct 2022 | 15.50m | 3.11% |
| The Vanguard Group, Inc.as of 09 May 2024 | 15.25m | 3.06% |
| Nomura Asset Management Co., Ltd.as of 30 Apr 2024 | 14.04m | 2.82% |
| BlackRock Japan Co. Ltd.as of 29 Mar 2024 | 8.94m | 1.79% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 7.32m | 1.47% |
| Nikko Asset Management Co., Ltd.as of 31 Oct 2022 | 7.14m | 1.43% |
| Daiwa Asset Management Co. Ltd.as of 30 Apr 2024 | 6.17m | 1.24% |
| Geode Capital Management LLCas of 30 May 2024 | 3.57m | 0.72% |
More ▼
Data from 31 Dec 2023 - 30 May 2024Source: FactSet Research Systems Inc.
